≥99.5% PURITY·HPLC VERIFIED·MASS SPEC CONFIRMED·USA SYNTHESIZED
Tesamorelin
Stabilised GHRH Analogue
$78.00
· per vial≥99.5%HPLCRUO
IN STOCK · SHIPS TODAY64 of batch remaining
- Batch
- VR-26-04-TES-01
- Sealed
- Apr 13, 2026
- Sequence
- trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Molecular Weight
- 5135.9 g/mol
- CAS Number
- 901758-09-6
- Appearance
- White lyophilized powder
- Storage
- −20°C, protected from light
Research Areas
- · Visceral adipose tissue research models
- · DPP-IV–resistant GHRH pharmacology
- · Long-acting GHRH pharmacokinetics
Quantity
1
⚠ For research use only. Not for human consumption.
Not approved by the FDA. Not for diagnostic use.
Not approved by the FDA. Not for diagnostic use.
Tesamorelin is a stabilised 44-amino-acid GHRH analogue with an N-terminal trans-3-hexenoyl modification that resists DPP-IV cleavage. Among the most-studied long-half-life GHRH analogues.